̽»¨Ö±²¥

Cambridge scientists have discovered that cancer cells ‘hijack’ a process used by healthy cells to spread around the body, completely changing current ways of thinking around cancer metastasis.

̽»¨Ö±²¥nine Cambridge researchers were all selected for their exceptional contributions to science.

Med-tech start-up has raised £1 million in its first round of funding to help it develop the NeutroCheck, a fully-integrated clinical, AI and medical device-based system for people living with cancer.  

DNA analysis of thousands of tumours from NHS patients has found a ‘treasure trove’ of clues about the causes of cancer, with genetic mutations providing a personal history of the damage and repair processes each patient has been through.

Marcel Gehrung, co-founder and CEO of rapidly growing Cambridge biotech company, Cyted, on revolutionising disease diagnostics and the challenges of building a business during a pandemic.  

Every patient with cancer has a story to tell of their journey through diagnosis and treatment. We meet a group of women who are at the centre of pioneering research in Cambridge that’s changing the outcome of ovarian cancer – helping to create treatments that are as unique as their stories.

GE Healthcare, the ̽»¨Ö±²¥ of Cambridge and Cambridge ̽»¨Ö±²¥ Hospitals have agreed to collaborate on developing an application aiming to improve cancer care, with Cambridge providing clinical expertise and data to support GE Healthcare’s development and evaluation of an AI-enhanced application that integrates cancer patient data from multiple sources into a single interface.

PREDICT Breast and Prostate, powerful online risk communication tools developed by Cambridge researchers, have helped thousands of patients across the world reach better clinical outcomes, avoid unnecessary treatments and suffer less distress.

Doctors at Addenbrooke’s Hospital in Cambridge aim to drastically cut cancer waiting times by using artificial intelligence (AI) to automate lengthy radiotherapy preparations.

Recruitment has begun at three leading Cambridgeshire NHS Trusts for volunteers to take part in the nationwide COVID-19 vaccine trial.